This study used breast cancer as a model to investigate the potential significance of VPS37D and other critical molecules in the remodeling of the tumor microenvironment and precision therapy, thereby offering a theoretical foundation for the advancement of tumor immunotherapy. The gene discussed is VPS37D; the disease is breast carcinoma.